{"id":"W2240796172","doi":"10.1200/jco.2009.27.15_suppl.e17539","title":"Sunitinib, sorafenib, temsirolimus, or bevacizumab in the treatment of metastatic renal cell carcinoma (RCC): A review of health economic evaluations","year":2009,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Sorafenib; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Cost effectiveness; Kidney cancer; Discovery and development of mTOR inhibitors; Hepatocellular carcinoma; Chemotherapy; PI3K/AKT/mTOR pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0129178,0.001570941,0.006763157,0.01129156,0.0004453343,0.002736545,0.001647992,0.001478094,0.002749509],"category_scores_gemma":[0.03742715,0.0007626449,0.00725082,0.01061166,0.0006379161,0.001704262,0.0009760099,0.001152235,0.0001555601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004293835,"about_ca_system_score_gemma":0.004764603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004235123,"about_ca_topic_score_gemma":0.009589056,"domain_scores_codex":[0.991713,0.004356705,0.002060469,0.0002962329,0.001370607,0.0002028914],"domain_scores_gemma":[0.9664456,0.02799703,0.003587113,0.0002079977,0.00153992,0.0002222586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001873157,0.00009682229,0.001777403,0.714645,0.02346819,0.000258581,0.0001313929,0.001230588,0.0001717737,0.001173348,0.004005159,0.2511684],"study_design_scores_gemma":[0.001599819,0.001289632,0.01134964,0.7829732,0.1415822,0.001012365,0.0004584829,0.001503493,0.0005479606,0.002518299,0.05506477,0.0001001636],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007238882,0.9984854,0.00006591099,0.0002532658,0.00004149765,0.0000562644,0.0001021472,0.000002556102,0.0002690539],"genre_scores_gemma":[0.01546187,0.983489,0.000420526,0.0002779713,0.0000593726,0.0001264185,0.0001098338,0.000003031402,0.00005199553],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0129178,"threshold_uncertainty_score":0.0683167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4362555027478233,"score_gpt":0.5691585290781784,"score_spread":0.1329030263303551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}